Medical Information
United States
 

In order to provide you with relevant and meaningful content we need to know more about you.

Please choose the category that best describes you.

This content is intended for U.S. Healthcare Professionals. Would you like to proceed?

I am a U.S. Healthcare ProfessionalYes, I am a U.S. Healthcare Professional
SelectI am a U.S. Healthcare ProfessionalYes, I am a U.S. Healthcare Professional
I am a U.S. Patient / CaregiverNo, go back to the patient portal
SelectI am a U.S. Patient / CaregiverNo, go back to the patient portal
Non-US residents click here.

If you provide additional keywords, you may be able to browse through our database of Scientific Response Documents.

Our scientific content is evidence-based, scientifically balanced and non-promotional. It undergoes rigorous internal medical review and is updated regularly to reflect new information.

PREMARIN® Principal Display Panel (conjugated estrogens)

PACKAGE LABEL - PRINCIPAL DISPLAY PANEL - 0.3 MG – LABEL

Pfizer

NDC 0046-1100-81

PREMARIN®
(conjugated estrogens
tablets, USP)

0.3 mg

100 Tablets

Rx only

PRINCIPAL DISPLAY PANEL - 0.3 MG – LABEL

PACKAGE LABEL - PRINCIPAL DISPLAY PANEL - 0.3 MG – CARTON

Pfizer

NDC 0046-1100-91
Rx only

PREMARIN®
(conjugated estrogens
tablets, USP)

0.3 mg

Note: Dispense in tight (USP), child-resistant containers.
This package not for household use.

1,000 Tablets

PRINCIPAL DISPLAY PANEL - 0.3 MG – CARTON

PACKAGE LABEL - PRINCIPAL DISPLAY PANEL - 0.3 MG – BLISTER CARD

NDC 0046-1100-51

PROFESSIONAL SAMPLE - NOT FOR SALE

PREMARIN®

(conjugated estrogens tablets, USP)

0.3 mg

Blister card contains five 0.3 mg tablets

Rx only

PRINCIPAL DISPLAY PANEL - 0.3 MG – BLISTER CARD

PANELPACKAGE LABEL - PRINCIPAL DISPLAY PANEL - 0.3 MG - POUCHES

NDC 0046-1100-51

PROFESSIONAL SAMPLE – NOT FOR SALE

PREMARIN®

(conjugated estrogens tablets, USP)

0.3 mg

Visit us at www.PREMARIN.com

Package contains: 1 blister card of 5 tables

Rx only

PRINCIPAL DISPLAY PANEL - 0.3 MG - POUCHES

PACKAGE LABEL - PRINCIPAL DISPLAY PANEL - 0.45 MG – LABEL

Pfizer

NDC 0046-1101-81

PREMARIN®
(conjugated estrogens
tablets, USP)

0.45 mg

100 Tablets

Rx only

PRINCIPAL DISPLAY PANEL - 0.45 MG – LABEL

PACKAGE LABEL - PRINCIPAL DISPLAY PANEL - 0.625 MG – LABEL

Pfizer

NDC 0046-1102-81

PREMARIN®
(conjugated estrogens
tablets, USP)

0.625 mg

100 Tablets

Rx only

PRINCIPAL DISPLAY PANEL - 0.625 MG – LABEL

PACKAGE LABEL - PRINCIPAL DISPLAY PANEL - 0.625 MG – BOTTLE CARTON

Pfizer

NDC 0046-1102-91
Rx only

PREMARIN®
(conjugated estrogens
tablets, USP)

0.625 mg

Note: Dispense in tight (USP), child-resistant containers.
This package not for household use.

1,000 Tablets

PRINCIPAL DISPLAY PANEL - 0.625 MG – BOTTLE CARTON

PACKAGE LABEL - PRINCIPAL DISPLAY PANEL - 0.625 MG - BLISTER CARD

NDC 0046-1102-51

PROFESSIONAL SAMPLE - NOT FOR SALE

PREMARIN®

(conjugated estrogens tablets, USP)

0.625 mg

Blister card contains five 0.625 mg tablets

Rx only

PRINCIPAL DISPLAY PANEL - 0.625 MG - BLISTER CARD

PACKAGE LABEL - PRINCIPAL DISPLAY PANEL - 0.625 MG - POUCHES

NDC 0046-1102-51

PROFESSIONAL SAMPLE – NOT FOR SALE

PREMARIN®

(conjugated estrogens tablets, USP)

0.625 mg

Package contains: 1 blister card of 5 tablets

Visit us at www.PREMARIN.com

Rx only

PRINCIPAL DISPLAY PANEL - 0.625 MG - POUCHES

PACKAGE LABEL - PRINCIPAL DISPLAY PANEL - 0.625 MG - CARTON

NDC 0046-1102-51

PROFESSIONAL SAMPLE – NOT FOR SALE

PREMARIN®

(conjugated estrogens tablets, USP)

0.625 mg

Package contains 10 pouches with 1 blister card of 5 tablets each

Visit us at www.PREMARIN.com

Rx only

PRINCIPAL DISPLAY PANEL - 0.625 MG -CARTON

PACKAGE LABEL - PRINCIPAL DISPLAY PANEL - 0.9 MG – LABEL

Pfizer

NDC 0046-1103-81

PREMARIN®
(conjugated estrogens
tablets, USP)

0.9 mg

100 Tablets

Rx only

PRINCIPAL DISPLAY PANEL - 0.9 MG – LABEL

PACKAGE LABEL - PRINCIPAL DISPLAY PANEL - 1.25 MG – LABEL

Pfizer

NDC 0046-1104-81

PREMARIN®
(conjugated estrogens
tablets, USP)

1.25 mg

100 Tablets

Rx only

PRINCIPAL DISPLAY PANEL - 1.25 MG – LABEL

PRINCIPAL DISPLAY PANEL - 1.25 mg Tablet Bottle Carton

Pfizer

NDC 0046-1104-91

PREMARIN®
(conjugated estrogens
tablets, USP)

1.25 mg

Note:
Dispense in tight (USP),
child-resistant containers.
This package not for household use.

1,000 Tablets

Rx only

PRINCIPAL DISPLAY PANEL - 1.25 mg Tablet Bottle Carton

PACKAGE LABEL - PRINCIPAL DISPLAY PANEL - 1.25 MG – BLISTER CARD

NDC 0046-1104-51

PROFESSIONAL SAMPLE - NOT FOR SALE

PREMARIN®

(conjugated estrogens tablets, USP)

1.25 mg

Blister card contains five 1.25 mg tablets

Rx only

PRINCIPAL DISPLAY PANEL - 1.25 MG – BLISTER CARD

PACKAGE LABEL - PRINCIPAL DISPLAY PANEL - 1.25 MG - POUCHES

NDC 0046-1104-51

PROFESSIONAL SAMPLE - NOT FOR SALE

PREMARIN®

(conjugated estrogens tablets, USP)

1.25 mg

Package contains: 1 blister card of 5 tablets

Visit us at www.PREMARIN.com

Rx only

PRINCIPAL DISPLAY PANEL - 1.25 MG - POUCHES

PACKAGE LABEL - PRINCIPAL DISPLAY PANEL - 1.25 MG - CARTON

NDC 0046-1104-51

PROFESSIONAL SAMPLE - NOT FOR SALE

PREMARIN®

(conjugated estrogens tablets, USP)

1.25 mg

Package contains 10 pouches with 1 blister card of 5 tablets each

Visit us at www.PREMARIN.com

Rx only

PRINCIPAL DISPLAY PANEL - 1.25 MG - CARTON
Show All Hide All
Show All Hide All
Did you find an answer to your question? Yes No
Didn’t find what you were looking for? Contact us.
MI Digital Assistant

Chat online with Pfizer Medical Information regarding your inquiry on a Pfizer medicine.

Call 800-438-1985*

*Contact Medical Information.

Medical Inquiry

Submit a medical question for Pfizer prescription products.

Report Adverse Event
Pfizer Safety

To report an adverse event related to a Pfizer product and you are not part of a clinical trial* for this product, click the link below to submit your information: Pfizer Safety Reporting Site

*If you are involved in a clinical trial for either product, adverse events should be reported to your coordinating study site.

If you cannot use the above website to report an adverse event related to a Pfizer product, please call Pfizer Medical Information at (800) 438-1985.

FDA Medwatch
You may also contact the U.S. Food and Drug Administration (FDA) directly to report adverse events or product quality concerns either online at www.fda.gov/medwatchor by calling
(800)-332-1088.